Delivery Order SPE2DB22D1017-SPE2DB26FYPGJ
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Synthroid 75 mcg tablets (1,000 count) with a ceiling value of $2,402.08. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and calls for delivery to Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,537.98 delivery order to AmerisourceBergen Drug Corp for 1,000 units of Synthroid 25 micrograms on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement under delivery order contract type. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the vendor is headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Synthroid 50 MCG tablets (1,000-unit quantity) valued at $1,355.36. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Levothyroxine 25 MCG tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,006.96, represents a non-competitive, non-set-aside award and will be completed by September 10, 2025. The place of performance is located at the company's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Synthroid 25 microgram tablets in quantities of 1,000 units. This firm fixed price delivery order carries a ceiling value of $8,685.79 and is scheduled for completion by October 27, 2025. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open...
- The Defense Logistics Agency (DLA) awarded a $11,495.75 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 125 mcg Synthroid tablets. This contract does not have a set-aside designation and has an ultimate completion date of September 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,590.90 firm-fixed-price delivery order is for the supply of 1,000 tablets of the medication SYNTHROID 25 MCG. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,252.01 firm fixed-price delivery order is for the supply of 4,567,490,367 units of Synthroid 75 MCG tablet, a medication used to treat hypothyroidism. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,180.65 contract is for the delivery of Synthroid 137 MCG tablets to the Conshohocken, Pennsylvania location. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp, which serves as the...
- The Defense Logistics Agency awarded a $15,640 delivery order to Amerisourcebergen Drug Corporation for the provision of 100 microgram Synthroid tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 90 bottles of the thyroid medication to a facility in Conshohocken, Pennsylvania by July 14, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 contractor on the DLA's Pharmaceutical Prime Vendor program, Amerisourcebergen regularly supplies...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB26FYPGJDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 16, 2025, for 1,000 tablets of Synthroid 75 micrograms. This competitively awarded, non-set-aside contract has a ceiling value of $1,482.33 and is priced on a firm fixed-price basis, with an ultimate completion date of October 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen's contract awards consistently demonstrate its capability to meet federal procurement requirements across multiple therapeutic domains, serving critical customers including the Defense Health Agency and U.S. Coast Guard through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/16/25 |